Kristen Stewart
Stock Analyst at CL King
(2.18)
# 2,681
Out of 4,711 analysts
27
Total ratings
60%
Success rate
3.37%
Average return
Main Sectors:
Stocks Rated by Kristen Stewart
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HAE Haemonetics | Initiates: Buy | $116 | $75.44 | +53.76% | 1 | Sep 13, 2024 | |
MMSI Merit Medical Systems | Initiates: Buy | $88 | $98.22 | -10.41% | 1 | Apr 11, 2024 | |
ITGR Integer Holdings | Initiates: Buy | n/a | $133.67 | - | 1 | Mar 14, 2024 | |
ICUI ICU Medical | Initiates: Buy | $110 | $156.82 | -29.86% | 1 | Dec 14, 2023 | |
IART Integra LifeSciences Holdings | Initiates: Buy | $50 | $21.80 | +129.36% | 1 | Nov 14, 2023 | |
OM Outset Medical | Initiates: Neutral | n/a | $1.21 | - | 1 | Aug 17, 2023 | |
MDT Medtronic | Initiates: Buy | $106 | $81.03 | +30.82% | 1 | Jun 30, 2023 | |
BSX Boston Scientific | Initiates: Buy | $64 | $88.95 | -28.05% | 1 | Jun 30, 2023 | |
AVNS Avanos Medical | Initiates: Buy | $31 | $16.08 | +92.79% | 4 | May 22, 2023 | |
CNMD CONMED | Initiates: Buy | $140 | $68.63 | +103.99% | 1 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $300 | $227.68 | +31.76% | 2 | Jul 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $182 | $144.47 | +25.98% | 2 | Apr 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $364.60 | - | 1 | Apr 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $82 | $74.81 | +9.17% | 5 | Jan 31, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $108 | $107.12 | +0.82% | 2 | Jan 3, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $251 → $255 | $178.16 | +43.13% | 2 | May 4, 2018 |
Haemonetics
Sep 13, 2024
Initiates: Buy
Price Target: $116
Current: $75.44
Upside: +53.76%
Merit Medical Systems
Apr 11, 2024
Initiates: Buy
Price Target: $88
Current: $98.22
Upside: -10.41%
Integer Holdings
Mar 14, 2024
Initiates: Buy
Price Target: n/a
Current: $133.67
Upside: -
ICU Medical
Dec 14, 2023
Initiates: Buy
Price Target: $110
Current: $156.82
Upside: -29.86%
Integra LifeSciences Holdings
Nov 14, 2023
Initiates: Buy
Price Target: $50
Current: $21.80
Upside: +129.36%
Outset Medical
Aug 17, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Medtronic
Jun 30, 2023
Initiates: Buy
Price Target: $106
Current: $81.03
Upside: +30.82%
Boston Scientific
Jun 30, 2023
Initiates: Buy
Price Target: $64
Current: $88.95
Upside: -28.05%
Avanos Medical
May 22, 2023
Initiates: Buy
Price Target: $31
Current: $16.08
Upside: +92.79%
CONMED
May 22, 2023
Initiates: Buy
Price Target: $140
Current: $68.63
Upside: +103.99%
Jul 9, 2020
Upgrades: Overweight
Price Target: $300
Current: $227.68
Upside: +31.76%
Apr 29, 2020
Maintains: Overweight
Price Target: $173 → $182
Current: $144.47
Upside: +25.98%
Apr 13, 2020
Downgrades: Underweight
Price Target: n/a
Current: $364.60
Upside: -
Jan 31, 2020
Maintains: Hold
Price Target: $79 → $82
Current: $74.81
Upside: +9.17%
Jan 3, 2019
Initiates: Hold
Price Target: $108
Current: $107.12
Upside: +0.82%
May 4, 2018
Maintains: Hold
Price Target: $251 → $255
Current: $178.16
Upside: +43.13%